VRNA logo

Verona Pharma (VRNA) Selling, general & administrative expenses

annual SGA:

$149.75M+$99.40M(+197.40%)
December 31, 2024

Summary

  • As of today (May 29, 2025), VRNA annual SGA is $149.75 million, with the most recent change of +$99.40 million (+197.40%) on December 31, 2024.
  • During the last 3 years, VRNA annual SGA has risen by +$115.84 million (+341.65%).
  • VRNA annual SGA is now at all-time high.

Performance

VRNA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAincome statement metrics

quarterly SGA:

$69.11M+$24.03M(+53.29%)
March 31, 2025

Summary

  • As of today (May 29, 2025), VRNA quarterly SGA is $69.11 million, with the most recent change of +$24.03 million (+53.29%) on March 31, 2025.
  • Over the past year, VRNA quarterly SGA has increased by +$48.68 million (+238.22%).
  • VRNA quarterly SGA is now at all-time high.

Performance

VRNA quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAincome statement metrics

TTM SGA:

-$2.15B-$164.40M(-8.26%)
March 31, 2025

Summary

  • As of today (May 29, 2025), VRNA TTM SGA is -$2.15 billion, with the most recent change of -$164.40 million (-8.26%) on March 31, 2025.
  • Over the past year, VRNA TTM SGA has dropped by -$2.22 billion (-3621.33%).
  • VRNA TTM SGA is now -20140128.04% below its all-time high of $10.70 thousand.

Performance

VRNA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRNAincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

VRNA Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+197.4%+238.2%-3621.3%
3 y3 years+341.6%+828.9%-6820.7%
5 y5 years+1399.6%+907.2%-10000.0%

VRNA Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+463.4%at high+1206.5%-106.4%at low
5 y5-yearat high+1399.6%at high+2078.8%-331.9%at low
alltimeall timeat high>+9999.0%at high>+9999.0%<-9999.0%at low

VRNA Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$69.11M(+53.3%)
$198.43M(+32.5%)
Dec 2024
$149.75M(+197.4%)
$45.09M(+28.1%)
$149.75M(+25.2%)
Sep 2024
-
$35.20M(-28.2%)
$119.64M(+22.3%)
Jun 2024
-
$49.03M(+140.0%)
$97.79M(+59.8%)
Mar 2024
-
$20.43M(+36.5%)
$61.20M(+21.5%)
Dec 2023
$50.35M(+89.4%)
$14.97M(+12.1%)
$50.35M(+15.2%)
Sep 2023
-
$13.35M(+7.3%)
$43.70M(+22.6%)
Jun 2023
-
$12.44M(+29.7%)
$35.64M(+24.1%)
Mar 2023
-
$9.59M(+15.2%)
$28.73M(+8.1%)
Dec 2022
$26.58M(-21.6%)
$8.32M(+57.3%)
$26.58M(+10.7%)
Sep 2022
-
$5.29M(-4.3%)
$24.01M(-18.9%)
Jun 2022
-
$5.53M(-25.7%)
$29.61M(-7.7%)
Mar 2022
-
$7.44M(+29.2%)
$32.06M(-5.4%)
Dec 2021
$33.91M(+13.9%)
$5.76M(-47.1%)
$33.91M(-14.4%)
Sep 2021
-
$10.88M(+36.3%)
$39.60M(+7.0%)
Jun 2021
-
$7.99M(-14.0%)
$37.01M(+15.0%)
Mar 2021
-
$9.28M(-19.0%)
$32.19M(+8.1%)
Dec 2020
$29.77M
$11.45M(+38.3%)
$29.77M(+43.4%)
Sep 2020
-
$8.28M(+161.2%)
$20.75M(+39.3%)
Jun 2020
-
$3.17M(-53.8%)
$14.89M(+3.3%)
DateAnnualQuarterlyTTM
Mar 2020
-
$6.86M(+181.6%)
$14.42M(+45.0%)
Dec 2019
$9.99M(+25.1%)
$2.44M(+0.5%)
$9.95M(+5.4%)
Sep 2019
-
$2.42M(-10.2%)
$9.44M(+6.5%)
Jun 2019
-
$2.70M(+13.0%)
$8.86M(+4.5%)
Mar 2019
-
$2.39M(+23.7%)
$8.48M(+4.2%)
Dec 2018
$7.99M(-1.4%)
$1.93M(+4.6%)
$8.14M(+7.8%)
Sep 2018
-
$1.85M(-20.3%)
$7.55M(-10.5%)
Jun 2018
-
$2.32M(+13.4%)
$8.44M(-2.8%)
Mar 2018
-
$2.04M(+52.2%)
$8.68M(+9.5%)
Dec 2017
$8.10M(+179.8%)
$1.34M(-50.9%)
$7.93M(+4.1%)
Sep 2017
-
$2.73M(+6.7%)
$7.62M(+29.9%)
Jun 2017
-
$2.56M(+99.0%)
$5.86M(+55.6%)
Mar 2017
-
$1.29M(+24.5%)
$3.77M(+51.9%)
Dec 2016
$2.89M(+16.6%)
$1.03M(+5.5%)
$2.48M(+71.4%)
Sep 2016
-
$979.70K(+109.4%)
$1.45M(+209.4%)
Jun 2016
-
$467.80K
$467.80K
Dec 2015
$2.48M(+39.0%)
-
-
Dec 2014
$1.79M(-6.7%)
-
-
Dec 2013
$1.91M(+30.1%)
-
-
Dec 2012
$1.47M(+4.8%)
-
-
Dec 2011
$1.40M
-
-

FAQ

  • What is Verona Pharma annual SGA?
  • What is the all time high annual SGA for Verona Pharma?
  • What is Verona Pharma annual SGA year-on-year change?
  • What is Verona Pharma quarterly SGA?
  • What is the all time high quarterly SGA for Verona Pharma?
  • What is Verona Pharma quarterly SGA year-on-year change?
  • What is Verona Pharma TTM SGA?
  • What is the all time high TTM SGA for Verona Pharma?
  • What is Verona Pharma TTM SGA year-on-year change?

What is Verona Pharma annual SGA?

The current annual SGA of VRNA is $149.75M

What is the all time high annual SGA for Verona Pharma?

Verona Pharma all-time high annual SGA is $149.75M

What is Verona Pharma annual SGA year-on-year change?

Over the past year, VRNA annual SGA has changed by +$99.40M (+197.40%)

What is Verona Pharma quarterly SGA?

The current quarterly SGA of VRNA is $69.11M

What is the all time high quarterly SGA for Verona Pharma?

Verona Pharma all-time high quarterly SGA is $69.11M

What is Verona Pharma quarterly SGA year-on-year change?

Over the past year, VRNA quarterly SGA has changed by +$48.68M (+238.22%)

What is Verona Pharma TTM SGA?

The current TTM SGA of VRNA is -$2.15B

What is the all time high TTM SGA for Verona Pharma?

Verona Pharma all-time high TTM SGA is $10.70K

What is Verona Pharma TTM SGA year-on-year change?

Over the past year, VRNA TTM SGA has changed by -$2.22B (-3621.33%)
On this page